Thus, since NFATc3 expression induces the Th1 differentiation, the decrease of this transcription factor in T cells may suppress the cellular immune activation in the CML niche [29, 30]. The gene discussed is NFATC3; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.